Glipizide is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Glipizide is in a class of medications called sulfonylureas. Glipizide lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently. This medication will only help lower blood sugar in people whose bodies produce insulin naturally. Glipizide is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may occur if high blood sugar is not treated). More info »
AT A GLANCE: THIS DRUG IN 2011
Medicare Part D Claims
Cost by state
|District of Columbia||3,637||$65.8K|
About This Data
ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2011 includes nearly 1.2 billion prescriptions written by 1.6 million doctors, nurses and other providers. This database lists about 364,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. About three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »
If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to firstname.lastname@example.org and we will update your information. If you have other questions about this data, send a note to email@example.com.